| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 1.043 | 7.485 | 527 | 517 | 91 | 0 | 6.956 | 59.060 |
| Total Income - EUR | - | - | 1.043 | 7.487 | 727 | 517 | 91 | 15.228 | 65.662 | 76.898 |
| Total Expenses - EUR | - | - | 837 | 7.365 | 490 | 430 | 2.462 | 15.228 | 53.436 | 84.768 |
| Gross Profit/Loss - EUR | - | - | 206 | 123 | 237 | 87 | -2.371 | 0 | 12.226 | -7.870 |
| Net Profit/Loss - EUR | - | - | 174 | 48 | 229 | 82 | -2.373 | 0 | 12.156 | -8.297 |
| Employees | - | - | 0 | 1 | 1 | 0 | 1 | 1 | 2 | 2 |
Check the financial reports for the company - Bioferma Niculesti Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 0 | 0 | 0 | 56.260 | 149.143 | 135.076 |
| Current Assets | - | - | 669 | 24.915 | 6.204 | 6.859 | 194.232 | 123.878 | 136.596 | 108.477 |
| Inventories | - | - | 0 | 0 | 204 | 200 | 196 | 9.895 | 11.994 | 1.748 |
| Receivables | - | - | 657 | 6.063 | 5.995 | 6.398 | 181.973 | 87.775 | 122.259 | 72.963 |
| Cash | - | - | 13 | 18.851 | 5 | 260 | 12.064 | 26.208 | 2.343 | 33.766 |
| Shareholders Funds | - | - | 218 | 262 | 487 | 559 | -1.826 | -1.832 | 10.330 | 1.975 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 819 | 24.652 | 5.718 | 6.299 | 15.166 | 49.963 | 85.486 | 67.739 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 180.892 | 132.006 | 189.923 | 173.839 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "113 - 113" | |||||||||
| CAEN Financial Year |
113
|
|||||||||
Comments - Bioferma Niculesti Srl